埃弗罗利斯通过诱导自性依赖于自性的铁灭菌来抑制肝细胞母细胞瘤
Haijin Huang1,2, Jinlong Yan3, Xianyun Xu4
1Department of Pediatric Surgery, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
Drug development research
|February 13, 2024
概括
埃弗罗利斯通过诱导癌细胞的自性依赖性铁亡来治疗肝母细胞瘤具有前途. 这种mTOR抑制剂增强细胞死亡途径,提供了潜在的新疗法策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝细胞母细胞瘤治疗仍然具有挑战性,现有疗法的疗效尚不确定.
- 埃弗罗利斯是一种哺乳动物的拉巴胺素 (mTOR) 抑制剂标,具有潜力,但需要在肝细胞瘤中进一步调查.
- 自和铁是关键的细胞过程,涉及到癌症的发展和治疗反应.
研究的目的:
- 为了研究everolimus的抗肝母细胞瘤作用.
- 为了阐明自和铁死在以恒利木斯为媒介的肝细胞母细胞瘤细胞死亡中的作用.
- 为了确定是否Everolimus诱导的铁亡是依赖于自的.
主要方法:
- 在体外 (HuH-6细胞) 和体内 (异种移植模型) 建立的肝母细胞瘤模型.
- 使用传输电子显微镜和蛋白质标记物 (LC3,贝克林1,p62) 评估自.
- 通过亡试验,反应性氧物种 (ROS) 测量,脂质过氧化标志物,铁含量和关键的亡相关蛋白质 (GPX4,SLC7A11) 评估了亡.
主要成果:
- 埃弗罗利斯显著增强了肝细胞瘤细胞的自,由自细胞形成的增加和改变LC3,贝克林1和p62表达体现出来.
- 埃弗罗利马斯诱导了亡和铁亡,其特征是ROS增加,脂质过氧化,铁积累,以及降低了谷氨酸水平和与铁亡相关的蛋白质表达.
- 用自尼布抑制自的抑制逆转了everolimus诱导的铁,证实了这个过程的自依赖性.
结论:
- 埃弗罗利莫斯在体外和体内都表现出显著的抗肝母细胞瘤活性.
- 该机制涉及诱导自性依赖于肝细胞母细胞瘤细胞中的铁亡.
- 埃弗罗利斯是肝细胞母细胞瘤的一种有前途的治疗药物,向关键细胞死亡途径.
更多相关视频
09:21Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
913
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
7.1K
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:16Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K